In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 30 for your search:
Drug:  poly ICLC
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UMCC-8038

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-M-8002

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PC-680

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000573370, UMDNJ-0120070076, 0120070076, NCT00553683

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: 05-115, RO1 NS055140, NCT00766753

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-0007, NCT01079741

7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: NCI-79-C-23, NCI-POB-7803

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCI-79-C-80, NCI-POB-7901, UMCC-7914

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-082

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8027

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-082A

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-PA-884, EST-P-A884

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-PB-484, EST-P-B484

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000258685, NABTC-0105, NCT00052715

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ABTC-0106 CDR0000287012, U01CA062399, ABTC-0106, NABTC01-06, NCT00058123

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NABTT-0501 CDR0000454915, U01CA062475, NABTT-0501, NCT00262730

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: UPCC 02710, UMGCC 0955, NCT01245673

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-16545, NCT01437605

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HS13-00655, BB-43984, NCT01984892

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8303, NCI-83-C-143, NCI-T83-1257B, T83-1257

21.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8803A, NCI-88-C-101A, NCI-T88-0005N, T88-0005

22.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8915A, NCI-90-C-48A, NCI-T89-0173N, T89-0173

23.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 05-086, NCT00374049

24.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HspE7-00101-0601, NCT00493545

25.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-15383, 106566, NCI-P-8215, NCT01008527
1   
New Search